Changeflow GovPing European Union

Recent changes

Favicon for changeflow.com

EPO Patent EP2026029097A1 on Novel Stem Cell Separation and Culturing

The European Patent Office has published patent application EP2026029097A1 concerning a method for separating and culturing novel stem cells. The patent application details isolated novel stem cells, a mesenchymal stem cell bank, and a method for providing mesenchymal stem cell information.

Routine Notice Healthcare
Favicon for changeflow.com

EPO Patent Application: Human Antibody Against Coronavirus Mutant Strain

The European Patent Office has published patent application EP2026029035A1 concerning a human antibody against a coronavirus mutant strain. The publication date is March 18, 2026, and the application includes various International Patent Classification codes related to antibodies and their therapeutic uses.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Application: Plant Autophagy Regulation for Protein Accumulation

The European Patent Office has published patent application EP2026030502A1 concerning the regulation of plant autophagy to enhance recombinant protein accumulation. The application details methods and compositions for improving protein production in plants, with a publication date of March 18, 2026.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Publication: Bioengineered Bacteria for Biofilm Curation

The European Patent Office has published a new patent application, EP2026030202A1, concerning the use of bioengineered bacteria for curating biofilms. The publication date is March 18, 2026, and it covers various International Patent Classifications related to medical treatments and biotechnology.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Publication: Intestinal Organoid and Method for Producing Same

The European Patent Office (EPO) has published patent application EP2026029043A1 concerning an intestinal organoid and a method for its production. The publication date is March 18, 2026. The inventors have not yet been designated.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Application: Modified Bacteria for Reproductive Health

The European Patent Office has published patent application EP2026030562A1 concerning modified bacteria for reproductive health. The publication date is March 18, 2026, and it includes IPC classifications related to biotechnology and pharmaceuticals. The designation of the inventor has not yet been filed.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Application EP2026030013A1: Clearing Senescent Cells

The European Patent Office has published patent application EP2026030013A1 concerning a method for clearing senescent cells using natural antibodies. The application was published on March 18, 2026, and lists designated states across Europe.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent: RNA Extraction and Detection from Urine Sample

The European Patent Office has published a new patent application, EP2026030605A1, detailing methods for RNA extraction and detection from urine samples. This publication is part of the EPO's regular bulletin for biotechnology-related inventions.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Publication EP2026029704A1: Dumbbell-shaped DNA vectors

The European Patent Office has published patent application EP2026029704A1 concerning dumbbell-shaped DNA vectors. The publication date is March 18, 2026, and it falls under the C12N IPC classification for biotechnology. No inventors have been designated yet.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Squid-derived conductive protein, manufacturing method, patent published Mar 18

Squid-derived conductive protein, manufacturing method, patent published Mar 18

Routine Notice

Showing 161–170 of 1,005 changes

1 15 16 17 18 19 101

Get European Union alerts

Daily digest of regulatory changes. AI-summarized, no noise.

Free. Unsubscribe anytime.